SK bioscience Co.,Ltd.
KRX:302440.KS
53800 (KRW) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities: | ||||||
| Net Income
| 22,317.719 | 122,451.95 | 355,139.277 | 32,889.712 | 14,677.405 | 420.845 |
| Depreciation & Amortization
| 34,764.703 | 27,236.409 | 18,775.305 | 16,527.436 | 14,543.238 | 6,594.926 |
| Deferred Income Tax
| 0 | 0 | 0 | -719.864 | -5,587.062 | 4,327.733 |
| Stock Based Compensation
| 0 | 0 | 0 | 575.454 | 300.237 | 25.02 |
| Change In Working Capital
| -18,391.696 | -208,378.665 | 44,000.929 | 66,407.706 | 8,061.487 | 1,114.223 |
| Accounts Receivables
| 71,167.576 | -44,647.416 | -398.647 | -14,609.697 | 12,254.972 | -12,664.522 |
| Inventory
| 52,888.273 | -96,229.843 | -70,337.103 | -31,573.385 | -6,887.871 | 6,876.125 |
| Accounts Payables
| -7,683.098 | -52,758.718 | 46,536.207 | -866.886 | 7,295.049 | -7,029.846 |
| Other Working Capital
| -134,764.447 | -14,742.688 | 68,200.472 | 113,457.674 | -4,600.663 | -5,761.902 |
| Other Non Cash Items
| -9,344.365 | -66,267.978 | 118,678.177 | 4,543.347 | 3,977.22 | 2,419.772 |
| Operating Cash Flow
| 29,346.361 | -124,958.284 | 536,593.688 | 120,223.791 | 35,972.525 | 14,902.519 |
| Investing Activities: | ||||||
| Investments In Property Plant And Equipment
| -50,295.489 | -76,489.443 | -44,469.56 | -10,197.57 | -23,968.408 | -6,309.972 |
| Acquisitions Net
| 0.535 | 34.566 | 5,819.51 | 197.839 | 99.922 | 0 |
| Purchases Of Investments
| -111,396.35 | -1,000.087 | -1,385,607.013 | -102,396.742 | -99.922 | -11,323.366 |
| Sales Maturities Of Investments
| 118,773.445 | 353,052.205 | 990 | 3,262.04 | 21,019.983 | 0 |
| Other Investing Activites
| -2,360.862 | -2,950.736 | 1,326.778 | 1,041.516 | 302.465 | -9.16 |
| Investing Cash Flow
| -45,278.721 | 272,646.505 | -1,421,940.285 | -108,092.918 | -2,645.959 | -17,642.498 |
| Financing Activities: | ||||||
| Debt Repayment
| -83,554 | -64,195.557 | -35,571.089 | -1,237.367 | -23,435.486 | -10,000 |
| Common Stock Issued
| 397.599 | 2,617.946 | 983,255.829 | -301.455 | 0 | 10,981.864 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -6,426.215 | 41,710.45 | 10,695.546 | -301.455 | 0 | -144 |
| Financing Cash Flow
| -89,582.616 | -19,867.162 | 958,380.287 | -1,538.822 | -23,435.486 | 837.864 |
| Other Information: | ||||||
| Effect Of Forex Changes On Cash
| 7,253.167 | -561.871 | 22.252 | 0 | 0 | -0 |
| Net Change In Cash
| -98,261.81 | 127,259.187 | 73,055.941 | 10,592.051 | 9,891.079 | -1,902.116 |
| Cash At End Of Period
| 127,025.639 | 225,287.448 | 98,028.261 | 24,972.321 | 14,380.269 | 4,489.19 |